These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 5597847)

  • 61. [Effects of carcinostatic agents on antibody formation. (2). Effects on 19S and 7S antibody formation].
    Futonaka H; Ishii H; Shin S; Inoue M; Furukawa K
    Gan No Rinsho; 1967 Mar; 13(3):160-5. PubMed ID: 6070071
    [No Abstract]   [Full Text] [Related]  

  • 62. Studies of immunity in typhoid fever. Protection induced by killed oral antigens or by primary infection.
    Dupont HL; Hornick RB; Snyder MJ; Dawkins AT; Heiner GG; Woodward TE
    Bull World Health Organ; 1971; 44(5):667-72. PubMed ID: 5316750
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Selective primary health care: strategies for control of disease in the developing world. XX. Typhoid fever.
    Hornick RB
    Rev Infect Dis; 1985; 7(4):536-46. PubMed ID: 2412272
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Preventive properties of immune sera as a criterium in the determination of immunogenic properties of typhoid cultures in vaccinal preparations].
    GINTSE LA
    Zh Mikrobiol Epidemiol Immunobiol; 1958 Oct; 29(10):93-8. PubMed ID: 13626079
    [No Abstract]   [Full Text] [Related]  

  • 65. [Quantitative determination of globulins. II. A study of serum from chronic carriers of typhoid bacteria].
    German GP; Chernokhvostova EV; Kalinina KI; Liuksemburg KI
    Zh Mikrobiol Epidemiol Immunobiol; 1972 Feb; 49(2):15-7. PubMed ID: 4623774
    [No Abstract]   [Full Text] [Related]  

  • 66. [A study of the avidity of Vi antibodies in typhoid fever patients and chronic carriers].
    Bunin KV; Firsanov VI; Kravtsov EG; Sukhoroslova LI; Kapuka LP
    Zh Mikrobiol Epidemiol Immunobiol; 1976 Oct; (10):65-9. PubMed ID: 1007716
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [The dynamics of 0-antibodies of various physico-chemical properties in typhoid fever treated with levomycetin and VI-antigen].
    Sukhoroslova LI
    Zh Mikrobiol Epidemiol Immunobiol; 1968; 45(10):111-4. PubMed ID: 5731554
    [No Abstract]   [Full Text] [Related]  

  • 68. Circulating immune complexes in typhoid fever.
    Pudifin DJ; Duursma J
    S Afr Med J; 1984 Dec; 66(24):921-2. PubMed ID: 6505905
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Formation of immunity to typhoid following immunization with alcoholic typho-paratyphoid B divaccine].
    Pinegin BV
    Zh Mikrobiol Epidemiol Immunobiol; 1966 Jun; 43(6):23-6. PubMed ID: 6004904
    [No Abstract]   [Full Text] [Related]  

  • 70. Humoral and cellular immune responses to Salmonella typhi in patients with typhoid fever.
    Mastroianni CM; Jirillo E; De Simone C; Grassi PP; Maffione AB; Catino AM; Vullo V; Misefari A; Delia S
    J Clin Lab Anal; 1989; 3(3):191-5. PubMed ID: 2754534
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Retrospective review of dot enzyme immunoassay test for typhoid fever in an endemic area.
    Jackson AA; Ismail A; Ibrahim TA; Kader ZS; Nawi NM
    Southeast Asian J Trop Med Public Health; 1995 Dec; 26(4):625-30. PubMed ID: 9139364
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Safety and immunogenicity of an attenuated Salmonella enterica serovar Paratyphi A vaccine candidate.
    Xiong K; Chen Z; Zhu C; Li J; Hu X; Rao X; Cong Y
    Int J Med Microbiol; 2015 Sep; 305(6):563-71. PubMed ID: 26239100
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Studies of combined quadruple vaccines against diphtheria, pertussis, tetanus, and typhoid fever: reactogenicity and antigenicity.
    Cvjetanovic B; Ikić D; Lane WR; Manhalter T; Tapa S
    Bull World Health Organ; 1972; 46(1):47-52. PubMed ID: 4537334
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The effect of 7S and 19S antibodies on the primary response to Salmonella typhi antigens.
    Fink CW; LoSpalluto JJ
    Immunology; 1967 Mar; 12(3):259-66. PubMed ID: 6020396
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Vi Capsular Polysaccharide Produced by Recombinant
    Xiong K; Zhu C; Chen Z; Zheng C; Tan Y; Rao X; Cong Y
    Front Cell Infect Microbiol; 2017; 7():135. PubMed ID: 28484685
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Research on the effectiveness of the product "Polidin-Dr. I. Cantacuzino". I. Non-specific action on anti-typhoid-paratyphoid and anti-tularemic agglutinins, opsonins and the leukocyte formula].
    Pencea I; Laşco N; Hoişie S; Lazăr M; Rădulesco A; Pozsgi N
    Arch Roum Pathol Exp Microbiol; 1964 Jun; 23(2):477-84. PubMed ID: 4961446
    [No Abstract]   [Full Text] [Related]  

  • 77. Reactivities of shark 19S and 7S IgM antibodies to Salmonella typhimurium.
    Schulkind ML; Robbins JB; Clem LW
    Nat New Biol; 1971 Apr; 230(14):182-3. PubMed ID: 4928924
    [No Abstract]   [Full Text] [Related]  

  • 78. Persistent efficacy of Vi conjugate vaccine against typhoid fever in young children.
    Mai NL; Phan VB; Vo AH; Tran CT; Lin FY; Bryla DA; Chu C; Schiloach J; Robbins JB; Schneerson R; Szu SC
    N Engl J Med; 2003 Oct; 349(14):1390-1. PubMed ID: 14523155
    [No Abstract]   [Full Text] [Related]  

  • 79. [Typhoid vaccination from an immunological point of view].
    Günther O
    Arb Paul Ehrlich Inst Georg Speyer Haus Ferdinand Blum Inst Frankf A M; 1970; 65():1-14. PubMed ID: 4926019
    [No Abstract]   [Full Text] [Related]  

  • 80. Decreased gut-associated IgA levels in patients with typhoid fever.
    Kaul MN; Misra RC; Agarwal SK; Saha K
    Scand J Immunol; 1980; 11(6):623-8. PubMed ID: 7444381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.